Copertina

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Promotes Wound Healing in Cirrhotic Patients With Post‐Splenectomy Complications

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Na Han, Xulong Yuan, Zhengcai Liu, Yuanping Xu, Shuqiang Yue, Yongquan Shi, Jun Tie
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Portal Hypertension & Cirrhosis
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Effects of Shunt Position on the Prognosis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhotic Esophagogastric Variceal Bleeding
di: Yi‐Han Yang, et al.
Pubblicazione: (2025)

Chinese Registry on Transjugular Intrahepatic Portosystemic Shunts (CN‐TIPS): Protocol for a Registry‐Based, Prospective Prognostic Study
di: Yi Xiang, et al.
Pubblicazione: (2026)

The Dynamic Evolution of Lipid Profiles Following Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis
di: Jiamin Xu, et al.
Pubblicazione: (2026)

Advances in Factors and Risk Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
di: Lixin Song, et al.
Pubblicazione: (2025)

Severe Thrombocytopenia Is Associated With Bleeding in Hepatocellular Carcinoma Patients Receiving Antiangiogenic Therapy
di: Jun Tie, et al.
Pubblicazione: (2026)

Postoperative TIPS Reaction in a Patient With Portal Vein Dysfunction
di: Qihao Du, et al.
Pubblicazione: (2025)

Preclinical Efficacy and Safety Evaluation of a Novel Controlled‐Expansion ePTFE‐Covered TIPS Stent in a Swine Model
di: Yi Xiang, et al.
Pubblicazione: (2026)

Radiomic Analysis of Contrast‐Enhanced CT Predicts Recompensation in Hepatitis B‐Related Decompensated Cirrhosis
di: Qiaofeng Chen, et al.
Pubblicazione: (2025)

Exploring the predictive value of serum lipids for short‐term prognosis in patients with acute‐on‐chronic liver failure
di: Yunfeng Fu, et al.
Pubblicazione: (2024)

LiverRCT IIT : Promoting Investigator‐Initiated Randomized Controlled Trials for the Key Clinical Issues in Liver Disease Prevention and Treatment
di: Xiaolong Qi, et al.
Pubblicazione: (2025)

Serum Creatinine of 1.1 mg/dL Can Indicate Disease Deterioration and 90‐day Mortality in Hospitalized Patients With Cirrhosis in Chinese Population
di: Lindan Xie, et al.
Pubblicazione: (2025)

Liver Fibrosis Tests and Outcomes of Bariatric Surgery in Morbidly Obese Patients With MASLD
di: Parinda Prathyajuta, et al.
Pubblicazione: (2026)

The Safety of Interferon‐Based Therapies in Chronic Hepatitis B Patients With Compensatory Cirrhosis
di: Qiran Zhang, et al.
Pubblicazione: (2026)

Capsule endoscopy in portal hypertension and varices
di: Jun Pan, et al.
Pubblicazione: (2024)

Factors Associated With Liver Fibrosis in Patients With Type 2 Diabetes and the Predictive Value of CHI3L1
di: Lixia Sun, et al.
Pubblicazione: (2026)

Predictive Value of Coagulation Factor VIII and Protein C Levels for Further Decompensated Events in Patients With Decompensated Cirrhosis
di: Siyu Jiang, et al.
Pubblicazione: (2025)

Correction to “Factors Associated With Liver Fibrosis in Patients With Type 2 Diabetes and the Predictive Value of CHI3L1”
Pubblicazione: (2026)

Epidemiological Characteristics of Acute‐on‐Chronic Liver Failure in Patients With Compensated Liver Disease: A Systematic Review and Meta‐Analysis
di: Lei Liu, et al.
Pubblicazione: (2025)

Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease
di: Rong Wang, et al.
Pubblicazione: (2026)

Resmetirom and Thyroid Hormone Receptor‐Targeted Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD)
di: Chang‐Hai Liu, et al.
Pubblicazione: (2025)

Bibliometric and visualized analysis of the correlation between sarcopenia and chronic liver diseases from 2000 to 2023
di: Jiaming Lan, et al.
Pubblicazione: (2024)

One‐year status of hepatic venous pressure gradient measurement from 85 hospitals in China
di: Jitao Wang, et al.
Pubblicazione: (2024)

Correction to “Multifrequency Multiparameter Magnetic Resonance Elastography Applied to an In Vivo Porcine Model for Assessing Portal Hypertension”
Pubblicazione: (2026)

Author Guidelines
Pubblicazione: (2024)

Liver Cirrhosis and Sleep Disorders
di: Jiawen Feng, et al.
Pubblicazione: (2025)

Dawn of an era of effective treatments for MAFLD
di: Cameron Gofton, et al.
Pubblicazione: (2024)

Massive Lower Gastrointestinal Bleeding Due to Colonic Telangiectasia
di: Xuan Ren, et al.
Pubblicazione: (2024)

Molecular mechanisms of hepatic lipid metabolism disorders: Focus on mitochondrial quality control
di: Jiachi Yu, et al.
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2025)

Endovascular embolization for upper gastrointestinal bleeding due to portal hypertension caused by a superior mesenteric arteriovenous fistula
di: Yu He, et al.
Pubblicazione: (2024)

Serum markers for detecting histological features of autoimmune hepatitis and predicting prognosis in patients with antinuclear antibody‐positive drug‐induced liver injury
di: Feiyu Zhang, et al.
Pubblicazione: (2024)

Correction to “Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)”
Pubblicazione: (2026)

Application of subharmonic‐aided pressure estimation in a patient with giant hepatic cyst: A case report
di: Xiuyun Lu, et al.
Pubblicazione: (2024)

Endoscopic Submucosal Dissection for Early Esophageal Squamous Cell Carcinoma Located at Esophageal Varices Caused by Liver Cirrhosis
di: Wenlan Zheng, et al.
Pubblicazione: (2025)

Endoscopic ultrasound‐guided portal pressure gradient identifies patients with previously undiagnosed clinically significant portal hypertension
di: Jerome C. Edelson, et al.
Pubblicazione: (2024)

Deep Learning‐Based Prediction of High‐Risk Gastroesophageal Varices Using Two‐Dimensional Shear Wave Elastography
di: Lan Wang, et al.
Pubblicazione: (2025)

When Fat Goes Astray: Your Liver and Pancreas Get Into Trouble
di: Yuying Chen, et al.
Pubblicazione: (2026)

Current Cell/Organoid and Animal Models for Primary Sclerosing Cholangitis
di: Qigu Yao, et al.
Pubblicazione: (2026)

Successful Embolization for Recurrent Encephalopathy Caused by Type II Abernethy Malformation
di: Hongliang Wang, et al.
Pubblicazione: (2025)

Disease Burden of Liver Cancer and Its Underlying Etiologies Globally and in China From 1990 to 2021: Results From the Global Burden of Disease Study 2021
di: Jiaqi Ruan, et al.
Pubblicazione: (2026)